292 related articles for article (PubMed ID: 20350641)
1. 17-alpha-hydroxyprogesterone caproate for the prevention of preterm birth in women with prior preterm birth and a short cervical length.
Berghella V; Figueroa D; Szychowski JM; Owen J; Hankins GD; Iams JD; Sheffield JS; Perez-Delboy A; Wing DA; Guzman ER;
Am J Obstet Gynecol; 2010 Apr; 202(4):351.e1-6. PubMed ID: 20350641
[TBL] [Abstract][Full Text] [Related]
2. The effect of 17α-hydroxyprogesterone caproate on preterm birth in women with an ultrasound-indicated cerclage.
Rafael TJ; Mackeen AD; Berghella V
Am J Perinatol; 2011 May; 28(5):389-94. PubMed ID: 21380984
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of 17-α-hydroxyprogesterone caproate on preterm birth prevention in women with history-indicated cerclage.
Mackeen AD; Rafael TJ; Zavodnick J; Berghella V
Am J Perinatol; 2013 Oct; 30(9):755-8. PubMed ID: 23341330
[TBL] [Abstract][Full Text] [Related]
4. Cerclage for the prevention of preterm birth in high risk women receiving intramuscular 17-α-hydroxyprogesterone caproate.
Szychowski JM; Berghella V; Owen J; Hankins G; Iams JD; Sheffield JS; Perez-Delboy A; Wing DA; Guzman ER;
J Matern Fetal Neonatal Med; 2012 Dec; 25(12):2686-9. PubMed ID: 22889234
[TBL] [Abstract][Full Text] [Related]
5. A randomized trial of cerclage vs. 17 alpha-hydroxyprogesterone caproate for treatment of short cervix.
Keeler SM; Kiefer D; Rochon M; Quinones JN; Novetsky AP; Rust O
J Perinat Med; 2009; 37(5):473-9. PubMed ID: 19492920
[TBL] [Abstract][Full Text] [Related]
6. 17-OHPC to Prevent Recurrent Preterm Birth in Singleton Gestations (PROLONG Study): A Multicenter, International, Randomized Double-Blind Trial.
Blackwell SC; Gyamfi-Bannerman C; Biggio JR; Chauhan SP; Hughes BL; Louis JM; Manuck TA; Miller HS; Das AF; Saade GR; Nielsen P; Baker J; Yuzko OM; Reznichenko GI; Reznichenko NY; Pekarev O; Tatarova N; Gudeman J; Birch R; Jozwiakowski MJ; Duncan M; Williams L; Krop J
Am J Perinatol; 2020 Jan; 37(2):127-136. PubMed ID: 31652479
[TBL] [Abstract][Full Text] [Related]
7. The Effect of Intramuscular 17α-Hydroxyprogesterone in Women Screened for Shortened Cervical Length.
Wood SL; Williams BN; Szychowski JM; Owen J
Am J Perinatol; 2020 Jun; 37(7):659-665. PubMed ID: 31756763
[TBL] [Abstract][Full Text] [Related]
8. Pregnancy outcomes of women receiving compounded 17 α-hydroxyprogesterone caproate for prophylactic prevention of preterm birth 2004 to 2011.
Sibai BM; Istwan NB; Palmer B; Stanziano GJ
Am J Perinatol; 2012 Sep; 29(8):635-42. PubMed ID: 22576126
[TBL] [Abstract][Full Text] [Related]
9. Can the optimal cervical length for placing ultrasound-indicated cerclage be identified?
Szychowski JM; Owen J; Hankins G; Iams JD; Sheffield JS; Perez-Delboy A; Berghella V; Wing DA; Guzman ER;
Ultrasound Obstet Gynecol; 2016 Jul; 48(1):43-7. PubMed ID: 26277877
[TBL] [Abstract][Full Text] [Related]
10. Cerclage for sonographic short cervix in singleton gestations without prior spontaneous preterm birth: systematic review and meta-analysis of randomized controlled trials using individual patient-level data.
Berghella V; Ciardulli A; Rust OA; To M; Otsuki K; Althuisius S; Nicolaides KH; Roman A; Saccone G
Ultrasound Obstet Gynecol; 2017 Nov; 50(5):569-577. PubMed ID: 28295722
[TBL] [Abstract][Full Text] [Related]
11. 17 alpha-hydroxyprogesterone caproate to prevent prematurity in nulliparas with cervical length less than 30 mm.
Grobman WA; Thom EA; Spong CY; Iams JD; Saade GR; Mercer BM; Tita AT; Rouse DJ; Sorokin Y; Wapner RJ; Leveno KJ; Blackwell S; Esplin MS; Tolosa JE; Thorp JM; Caritis SN; Van Dorsten JP;
Am J Obstet Gynecol; 2012 Nov; 207(5):390.e1-8. PubMed ID: 23010094
[TBL] [Abstract][Full Text] [Related]
12. Cerclage, progesterone and α-hydroxyprogeterone caproate treatment in women at risk for preterm delivery.
Haram K; Mortensen JH; Morrison JC
J Matern Fetal Neonatal Med; 2014 Nov; 27(16):1710-5. PubMed ID: 24678618
[TBL] [Abstract][Full Text] [Related]
13. Role of Cervical Cerclage and Vaginal Progesterone in the Treatment of Cervical Incompetence with/without Preterm Birth History.
Wang SW; Ma LL; Huang S; Liang L; Zhang JR
Chin Med J (Engl); 2016 Nov; 129(22):2670-2675. PubMed ID: 27823998
[TBL] [Abstract][Full Text] [Related]
14. Patient characteristics associated with 17-alpha hydroxyprogesterone caproate use among a high-risk cohort.
Turitz AL; Bastek JA; Purisch SE; Elovitz MA; Levine LD
Am J Obstet Gynecol; 2016 Apr; 214(4):536.e1-536.e5. PubMed ID: 26519784
[TBL] [Abstract][Full Text] [Related]
15. Progesterone and preterm birth prevention: translating clinical trials data into clinical practice.
Society for Maternal-Fetal Medicine Publications Committee, with assistance of Vincenzo Berghella
Am J Obstet Gynecol; 2012 May; 206(5):376-86. PubMed ID: 22542113
[TBL] [Abstract][Full Text] [Related]
16. Vaginal progesterone is as effective as cervical cerclage to prevent preterm birth in women with a singleton gestation, previous spontaneous preterm birth, and a short cervix: updated indirect comparison meta-analysis.
Conde-Agudelo A; Romero R; Da Fonseca E; O'Brien JM; Cetingoz E; Creasy GW; Hassan SS; Erez O; Pacora P; Nicolaides KH
Am J Obstet Gynecol; 2018 Jul; 219(1):10-25. PubMed ID: 29630885
[TBL] [Abstract][Full Text] [Related]
17. Recurrent preterm birth in women treated with 17 α-hydroxyprogesterone caproate: the contribution of risk factors in the penultimate pregnancy.
Coleman S; Wallace L; Alexander J; Istwan N
J Matern Fetal Neonatal Med; 2012 Jul; 25(7):1034-8. PubMed ID: 21854134
[TBL] [Abstract][Full Text] [Related]
18. Outcomes With Cerclage Alone Compared With Cerclage Plus 17α-Hydroxyprogesterone Caproate.
Stetson B; Hibbard JU; Wilkins I; Leftwich H
Obstet Gynecol; 2016 Nov; 128(5):983-988. PubMed ID: 27741201
[TBL] [Abstract][Full Text] [Related]
19. Relationship between interpregnancy interval and cervical length in high-risk women.
Subramaniam A; Wetta LL; Owen J
J Matern Fetal Neonatal Med; 2016; 29(8):1205-8. PubMed ID: 25983138
[TBL] [Abstract][Full Text] [Related]
20. 17 alpha-hydroxyprogesterone caproate does not prolong pregnancy or reduce the rate of preterm birth in women at high risk for preterm delivery and a short cervix: a randomized controlled trial.
Winer N; Bretelle F; Senat MV; Bohec C; Deruelle P; Perrotin F; Connan L; Vayssière C; Langer B; Capelle M; Azimi S; Porcher R; Rozenberg P;
Am J Obstet Gynecol; 2015 Apr; 212(4):485.e1-485.e10. PubMed ID: 25448515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
